No Need to Google: AI Explains Lab Results to Patients in Moscow Region
In Russia, a new artificial intelligence-based service has been launched to interpret laboratory test results. Integrated into the Dobrodel Zdorovye app, the module not only explains results but also provides personalized recommendations when values fall outside the normal range.
Since early 2026, around 35,000 residents of the Moscow Region have received their lab results not just as numbers and abbreviations, but with clear, plain-language explanations. The AI-based service, embedded in the regional Dobrodel Zdorovye (Dobrodel Health) app, reviews each parameter, compares it with reference values, and flags deviations. It also offers tailored guidance on what to monitor and which specialist to consult.
Algorithm, Not Guesswork
Previously, patients typically received lab reports with highlighted abnormalities but little explanation. They then had to search online, compare symptoms, worry, call support lines, or schedule a doctor visit just to understand whether a result was concerning. Now, part of that process is handled by AI. It does not make diagnoses or replace clinicians, but it helps patients interpret results and decide whether immediate medical attention is needed.
Notably, this is a fully integrated service within the region’s public digital health ecosystem, and it is already in active use.
How It Works
A patient visits a clinic and completes lab tests. The results are uploaded into a unified laboratory system and then delivered to the app. At that point, a neural network trained on thousands of anonymized lab records analyzes the data. It considers factors such as age, sex, individual indicators, and their combinations. Instead of simply flagging “high cholesterol,” the system generates an explanation such as: “Your low-density lipoprotein level is elevated, which may indicate an increased risk of cardiovascular disease. This may be related to diet. We recommend adjusting your nutrition and consulting a primary care physician.”
For the regional healthcare system, the tool helps reduce pressure on medical staff. Fewer patients call contact centers to ask what specific markers mean. Fewer healthy individuals visit physicians simply due to confusion over lab reports. Clinicians can focus more time on patients who require medical care.
What It Means for Patients
The main benefits are speed and reassurance. Patients no longer need to interpret complex medical terminology on their own. A result such as “leukocytes 12.5” can be quickly explained in context. If values are normal, the system confirms that there is no cause for concern. If abnormalities are detected, it indicates the appropriate specialist and urgency level.
This is particularly valuable for older patients who are less likely to search for explanations online, as well as for parents concerned about their children’s health.
What It Means for Russia
For the Moscow Region, the service is part of a broader digital healthcare ecosystem. The region has already invested in AI tools, including clinical decision support systems for imaging analysis. The addition of patient-facing lab interpretation extends this ecosystem further.
At the national level, the project represents a practical example of digital health implementation in the public sector. While digital transformation is widely discussed, working solutions with tens of thousands of users remain relatively rare. The Moscow Region demonstrates that such systems can be deployed without relying on large budgets or foreign IT vendors.
The service uses domestically developed or adapted AI models integrated into existing infrastructure. It also contributes to the region’s digital maturity. As more tools like this are introduced, patients become more comfortable using digital health services, increasing trust in remote channels while gradually reducing pressure on in-person care.
Affordable, Scalable, and Practical
The World Health Organization has emphasized in 2025–2026 that AI is already reshaping healthcare systems, but the key challenge lies not in building advanced algorithms, but in deploying them safely in clinical practice with transparent rules and strong data protection.
The Moscow Region provides a working model. For developing countries that lack resources for expensive Western platforms, this approach offers a viable alternative. Instead of building complex infrastructure, it relies on training models on local data and integrating them into existing applications. This makes the solution cost-effective, scalable, and easy to adopt. The next steps are clear: expanding the range of supported tests, incorporating patient history, and integrating with telemedicine and care routing systems.
In the future, such AI assistants are expected to become part of every patient’s digital health profile.
